Bharat Biotech

Centre Signs PPP With Bharat Biotech For Development Plus Commercial Production Of Intranasal Covid-19 And Malaria Vaccines
Centre Signs PPP With Bharat Biotech For Development Plus Commercial Production Of Intranasal Covid-19 And Malaria VaccinesSwarajya StaffMar 27, 2022 01:51 PM +05:30 IST
Bharat Biotech Gets DCGI Nod For Phase 3 Trials Of Its Intra-Nasal COVID-19 Vaccine
Bharat Biotech Gets DCGI Nod For Phase 3 Trials Of Its Intra-Nasal COVID-19 VaccinePTIJan 28, 2022 04:16 PM +05:30 IST
Omicron Is Behaving More Rationally Than Politicians And Media, Who Are Part Of The Problem
Omicron Is Behaving More Rationally Than Politicians And Media, Who Are Part Of The ProblemR JagannathanJan 6, 2022 04:24 PM +05:30 IST
Bharat Biotech Gets DCGI Panel's Approval For Phase 3 Trials Of Intranasal COVID-19 Vaccine As Booster Shot: Report
Bharat Biotech Gets DCGI Panel's Approval For Phase 3 Trials Of Intranasal COVID-19 Vaccine As Booster Shot: ReportSwarajya StaffJan 5, 2022 05:29 PM +05:30 IST
Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna Ella
Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna EllaBhaswati Guha Majumder Nov 29, 2021 06:23 PM +05:30 IST
UK Adds Bharat Biotech's Covaxin To Its List Of Approved COVID-19 Vaccines For International Travellers
UK Adds Bharat Biotech's Covaxin To Its List Of Approved COVID-19 Vaccines For International TravellersSwarajya StaffNov 23, 2021 10:53 AM +05:30 IST
Lost 10 Years Of Life In Past 18 Months Due To Stress And Excitement Of Developing Covaxin: Dr Krishna Ella
Lost 10 Years Of Life In Past 18 Months Due To Stress And Excitement Of Developing Covaxin: Dr Krishna Ella Swarajya StaffNov 14, 2021 08:57 AM +05:30 IST
Bharat Biotech Chairman Dr Krishna Ella Slams Biased Media Coverage And Domestic Politics Around Covaxin: "It Really Hurts"
Bharat Biotech Chairman Dr Krishna Ella Slams Biased Media Coverage And Domestic Politics Around Covaxin: "It Really Hurts"Swarajya StaffNov 12, 2021 03:34 PM +05:30 IST
Covaxin Phase 3 Trial Data Shows 77.8 Per Cent Efficacy Against Symptomatic COVID, Finds Study Published In Lancet
Covaxin Phase 3 Trial Data Shows 77.8 Per Cent Efficacy Against Symptomatic COVID, Finds Study Published In LancetSwarajya StaffNov 12, 2021 10:05 AM +05:30 IST
Booster Doses? Vaccination For Children? SUTRA Team Answers Your Questions
Booster Doses? Vaccination For Children? SUTRA Team Answers Your QuestionsThe SUTRA TeamNov 10, 2021 11:43 AM +05:30 IST
Zydus Cadila To Enter Vaccine Space By Supplying 1 Crore Of Its Plasmid DNA Vaccine Shots To Centre; Read Other Details Here
Zydus Cadila To Enter Vaccine Space By Supplying 1 Crore Of Its Plasmid DNA Vaccine Shots To Centre; Read Other Details HereBhaswati Guha Majumder Nov 9, 2021 12:57 PM +05:30 IST
US Biotech Company Ocugen Files IND Application With FDA For Bharat Biotech's Covaxin Clinical Trials
US Biotech Company Ocugen Files IND Application With FDA For Bharat Biotech's Covaxin Clinical TrialsBhaswati Guha Majumder Oct 28, 2021 02:33 PM +05:30 IST
WHO Seeks 'Additional Clarifications' From Bharat Biotech For Covaxin To Conduct Final 'Risk-Benefit Assessment'
WHO Seeks 'Additional Clarifications' From Bharat Biotech For Covaxin To Conduct Final 'Risk-Benefit Assessment' PTIOct 27, 2021 09:54 AM +05:30 IST
What Can Possibly Explain WHO's Delay In Approving Covaxin?
What Can Possibly Explain WHO's Delay In Approving Covaxin?Bhaswati Guha Majumder Oct 20, 2021 07:16 PM +05:30 IST
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The Pipeline
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The PipelineBhaswati Guha Majumder Oct 13, 2021 01:00 PM +05:30 IST
GSK-Bharat Biotech Partnership To Produce World's First Malaria Vaccine Approved By WHO
GSK-Bharat Biotech Partnership To Produce World's First Malaria Vaccine Approved By WHOSwarajya StaffOct 8, 2021 10:33 AM +05:30 IST
Final Decision On Approval To Bharat Biotech's Covaxin To Be Taken Next Week: WHO
Final Decision On Approval To Bharat Biotech's Covaxin To Be Taken Next Week: WHOSwarajya StaffOct 6, 2021 10:38 AM +05:30 IST
India To Buy 27-28 Crore COVID-19 Vaccine Doses From SII, Bharat Biotech In October: Report
India To Buy 27-28 Crore COVID-19 Vaccine Doses From SII, Bharat Biotech In October: ReportSwarajya StaffOct 1, 2021 10:32 AM +05:30 IST
Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11
Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11Bhaswati Guha Majumder Sep 29, 2021 04:37 PM +05:30 IST
Bharat Biotech Completes Phase 2/3 Trials Of Covaxin In Children Aged Below 18 Years
Bharat Biotech Completes Phase 2/3 Trials Of Covaxin In Children Aged Below 18 YearsSwarajya StaffSep 22, 2021 01:35 PM +05:30 IST
Load More